Hedelix S.A. (Extract Of Hedera Helix Folium (2.2 – 2.9 : 1), Extracting Agent: Ethanol 50% (V / V), Propylene Gly)

Hedelix S.A. is used as an herbal adjunct in the supportive management of respiratory conditions where mucous clearance is desired. It is typically taken as a short‑term supplement during symptomatic periods.

• Relief of occasional cough associated with minor throat irritation.
• Support of bronchial secretions clearance in mild upper‑respiratory tract infections.
• Adjunctive use during seasonal allergic rhinitis to ease post‑nasal drip.
• Temporary soothing of throat discomfort caused by dry air or voice strain.
• Complementary option for individuals seeking a plant‑based respiratory aid.

Reported adverse reactions to Hedelix S.A. are generally mild and reversible, but rare serious events have been documented in isolated cases.

Common

• Mild gastrointestinal discomfort such as nausea or stomach upset.
• Transient taste alteration or a slight bitter aftertaste.
• Mild skin irritation at the oral mucosa.
• Temporary increase in salivation.
• Light‑headedness or mild dizziness, especially when standing quickly.
• Dry mouth sensation after ingestion.
• Occasional mild headache that resolves without intervention.
• Slight increase in bowel movements or loose stools.
• Temporary metallic taste sensation.

Serious

• Allergic reactions including urticaria, angioedema, or anaphylaxis.
• Hepatic enzyme elevation in susceptible individuals.
• Severe bronchospasm in patients with pre‑existing asthma.

When considering Hedelix S.A., certain precautionary measures should be observed to ensure safe use.

• Avoid use in individuals with known hypersensitivity to ivy leaf or any formulation components.
• Do not exceed the recommended duration of short‑term use without professional guidance.
• Pregnant or breastfeeding persons should consult a healthcare professional before taking the product.
• Patients with liver disease should use caution and monitor hepatic function if advised.
• Children under the age of 12 should not use the preparation unless directed by a clinician.
• Concomitant use with other mucolytic or expectorant agents should be discussed with a pharmacist.

Potential interactions with Hedelix S.A. are limited, but awareness of concurrent substances is advisable.

Avoid

• Concurrent use with monoamine oxidase inhibitors (MAOIs) is not recommended due to theoretical risk of enhanced serotonergic activity.
• Simultaneous intake of high‑dose ethanol‑containing products should be avoided to prevent excessive alcohol exposure.

Use with caution

• Combining with other herbal expectorants (e.g., thyme, licorice) may increase mucolytic effect and cause gastrointestinal upset.
• Use with caution in patients taking anticoagulants, as ivy leaf may possess mild antiplatelet activity.
• Caution is advised when taken alongside antihistamines, as additive sedative effects have been reported anecdotally.